Operating Income for Biogen (BIIB)
According to Biogen's latest reported financial statements, the company's current operating income (TTM) is $1.88B USD. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
BIIB
Currently viewingOperating IncomeSwitch metric
TTM (last 4 quarters)
$1.88B
YoY change
-24.6%
5Y CAGR
-16.4%
Peak year (2019)
$7.04B
Cumulative operating income
$61.04B
Operating Income history chart for Biogen (BIIB) from 1985 to 2025
Operating Income history table for Biogen (BIIB) from 1985 to 2025
| Fiscal year | Period ended | Reported | Operating Income | YoY |
|---|---|---|---|---|
| 2025 | $1.88B | -24.6% | ||
| 2024 | $2.49B | +18.7% | ||
| 2023 | $2.10B | -27.4% | ||
| 2022 | $2.89B | +3.5% | ||
| 2021 | $2.79B | -39.2% | ||
| 2020 | $4.59B | -34.8% | ||
| 2019 | $7.04B | +19.6% | ||
| 2018 | $5.89B | +10.2% | ||
| 2017 | $5.35B | +3.8% | ||
| 2016 | $5.15B | +5.3% | ||
| 2015 | $4.89B | +23.1% | ||
| 2014 | $3.97B | +57.9% | ||
| 2013 | $2.52B | +36.8% | ||
| 2012 | $1.84B | +6.6% | ||
| 2011 | $1.72B | +38.1% | ||
| 2010 | $1.25B | -3.6% | ||
| 2009 | $1.30B | +6.7% | ||
| 2008 | $1.21B | +55.6% | ||
| 2007 | $779.77M | +77.2% | ||
| 2006 | $440.02M | +86.4% | ||
| 2005 | $236.04M | +443.7% | ||
| 2004 | $43.42M | -105.0% | ||
| 2003 | -$869.67M | -506.6% | ||
| 2002 | $213.88M | -40.6% | ||
| 2001 | $360.20M | +9.7% | ||
| 2000 | $328.36M | +3.8% | ||
| 1999 | $316.25M | +65.9% | ||
| 1998 | $190.64M | +28.0% | ||
| 1997 | $148.97M | +264.9% | ||
| 1996 | $40.83M | +448.4% | ||
| 1995 | $7.45M | -490.4% | ||
| 1994 | -$1.91M | -108.8% | ||
| 1993 | $21.70M | -24.1% | ||
| 1992 | $28.60M | -2300.0% | ||
| 1991 | -$1.30M | -262.5% | ||
| 1990 | $800,000 | -108.9% | ||
| 1989 | -$9.00M | -24.4% | ||
| 1988 | -$11.90M | -50.8% | ||
| 1987 | -$24.20M | -16.8% | ||
| 1986 | -$29.10M | -11.6% | ||
| 1985 | -$32.90M | — |
Operating Income values are taken from Biogen's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual operating income for Biogen (BIIB) came in at $1.88B – declined 24.6% year-over-year.
Biogen operating income compound annual growth for the 2020–2025 (5 years) window is -16.4%, with a net decline across the window.
Between 2019 and 2025, Biogen operating income plunged 73.3%, falling from $7.04B to $1.88B.
The highest annual operating income of $7.04B was reported in 2019. The lowest in the available history was -$869.67M in 2003.
Within Healthcare, Biogen (BIIB) ranks 9th among 8 peers we track. The peer median for operating income is $22.84B.
Biogen Operating Income by Year
Biogen Operating Income 2025: $1.88B
Biogen operating income in 2025 was $1.88B, declined 24.6% below 2024.
Biogen Operating Income 2024: $2.49B
Biogen operating income in 2024 was $2.49B, grew 18.7% from 2023.
Biogen Operating Income 2023: $2.10B
Biogen operating income in 2023 was $2.10B, declined 27.4% below 2022.
Biogen Operating Income 2022: $2.89B
Biogen operating income in 2022 was $2.89B, edged up 3.5% from 2021.
Biogen Operating Income 2021: $2.79B
Biogen operating income in 2021 was $2.79B.
See more financial history for Biogen (BIIB).
Sector peers — Operating Income
Companies in the same sector as Biogen, ranked by their latest operating income.
| Company | Operating Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $127.66B | Healthcare |
| Eli Lilly and Company (LLY) | $29.70B | Healthcare |
| Merck & Co., Inc. (MRK) | $26.78B | Healthcare |
| Johnson & Johnson (JNJ) | $25.60B | Healthcare |
| AbbVie Inc. (ABBV) | $20.09B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $18.96B | Healthcare |
| AstraZeneca PLC (AZN) | $13.74B | Healthcare |
| Amgen Inc. (AMGN) | $10.68B | Healthcare |
Frequently asked questions
What is Biogen's operating income?
- Latest reported operating income for Biogen (BIIB) is $1.88B (period ending December 31, 2025).
How has Biogen operating income changed year-over-year?
- Biogen (BIIB) operating income changed -24.6% year-over-year on the latest annual filing.
What is the long-term growth rate of Biogen operating income?
- Biogen (BIIB) operating income compound annual growth rate is -16.4% over the most recent 5 years available.
When did Biogen operating income hit its highest annual value?
- Biogen operating income reached its highest annual value of $7.04B in 2019.
What was Biogen operating income in 2024?
- Biogen (BIIB) operating income in 2024 was $2.49B.
What was Biogen operating income in 2025?
- Biogen (BIIB) operating income in 2025 was $1.88B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BIIB Overview
Company profile, financial tools, and key metrics
BIIB Revenue Counter
Earns $311.09 every second. See per minute, hour, and day.
BIIB Earnings Counter
Earns $41.01 per second net profit. See per minute, hour, and day.
BIIB Economic Scale
Exceeds Bermuda's GDP. Compare with world economies.
BIIB What If Invested
What if you had invested $1,000? See historical returns from any date.
BIIB How It Makes Money
Discover visual breakdown of $9.81B in revenue — where it comes from and where it goes.
BIIB Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BIIB Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BIIB Daily Price Character
Explosive · 48.1% historical win rate (green days). Streaks & record days.
BIIB Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BIIB Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.